J&J Begins Two-Dose Trial Of Its Covid-19 Vaccine ...Middle East

Ommcom News - News
J&J Begins Two-Dose Trial Of Its Covid-19 Vaccine
New York: Drugmaker Johnson & Johnson has launched the Phase 3 trials of the two-dose regimen of its investigational vaccine candidate for the prevention of Covid-19. The vaccine candidate, JNJ-78436735, is being developed by the Janssen Pharmaceutical Companies of Johnson & Johnson. The company is starting the two-dose trial in addition to the Phase 3 … The post J&J Begins Two-Dose Trial Of Its Covid-19 Vaccine appeared first on Ommcom News.

Hence then, the article about j j begins two dose trial of its covid 19 vaccine was published today ( ) and is available on Ommcom News ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( J&J Begins Two-Dose Trial Of Its Covid-19 Vaccine )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News
myMOTHERLODE - before 5 hours & 20 minute